Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospective observational trial aimed at identifying new biomarkers of acute heart failure in circulatory shock, by means of a multiscale analysis of blood samples and hemodynamic data from subjects with circulatory shock. Methods and Design: Ninety septic shock and cardiogenic shock patients will be recruited in three intensive care units (ICU) (Hôpital Erasme, Université Libre de Bruxelles, Belgium; Hospital Universitari Mutua Terrassa, Spain; Hôpitaux Universitaires de Genève, Switzerland). Hemodynamic signals will be recorded every day for up to seven days from shock diagnosis (time T0). Clinical data and blood samples will be collected for analysis at: i) T1 < 16 h from T0; ii) T2 = 48 h after T0; iii) T3 = day 7 or before discharge or before discontinuation of therapy in case of fatal outcome; iv) T4 = day 100. Discussion: ShockOmics will provide new insights into the pathophysiological mechanisms underlying shock as well as new biomarkers for the timely diagnosis of cardiac dysfunction in shock and quantitative indices for assisting the therapeutic management of shock patients.
ShockOmics : multiscale approach to the identification of molecular biomarkers in acute heart failure induced by shock / F. Aletti, C. Conti, M. Ferrario, V. Ribas, B. Bollen Pinto, A. Herpain, E. Post, E. Romay Medina, C. Barlassina, E. de Oliveira, R. Pastorelli, G. Tedeschi, G. Ristagno, F.S. Taccone, G.W. Schmid Schönbein, R. Ferrer, D. De Backer, K. Bendjelid, G. Baselli. - In: SCANDINAVIAN JOURNAL OF TRAUMA, RESUSCITATION AND EMERGENCY MEDICINE. - ISSN 1757-7241. - 24:1(2016 Jan 28), pp. 9.1-9.10. [10.1186/s13049-016-0197-4]
ShockOmics : multiscale approach to the identification of molecular biomarkers in acute heart failure induced by shock
C. Conti;C. Barlassina;G. Tedeschi;G. Ristagno;
2016
Abstract
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospective observational trial aimed at identifying new biomarkers of acute heart failure in circulatory shock, by means of a multiscale analysis of blood samples and hemodynamic data from subjects with circulatory shock. Methods and Design: Ninety septic shock and cardiogenic shock patients will be recruited in three intensive care units (ICU) (Hôpital Erasme, Université Libre de Bruxelles, Belgium; Hospital Universitari Mutua Terrassa, Spain; Hôpitaux Universitaires de Genève, Switzerland). Hemodynamic signals will be recorded every day for up to seven days from shock diagnosis (time T0). Clinical data and blood samples will be collected for analysis at: i) T1 < 16 h from T0; ii) T2 = 48 h after T0; iii) T3 = day 7 or before discharge or before discontinuation of therapy in case of fatal outcome; iv) T4 = day 100. Discussion: ShockOmics will provide new insights into the pathophysiological mechanisms underlying shock as well as new biomarkers for the timely diagnosis of cardiac dysfunction in shock and quantitative indices for assisting the therapeutic management of shock patients.File | Dimensione | Formato | |
---|---|---|---|
Scandinavian_J_Trauma.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
640.37 kB
Formato
Adobe PDF
|
640.37 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.